Antares Pharma, Inc. AIS today announced it has priced a firm commitment underwritten public offering of 12,500,000 shares of the Company's common stock at a purchase price of $1.60 per share for an aggregate gross offering amount of $20.0 million. The offering is expected to close on or about May 18, 2011, subject to customary closing conditions.
The Company has also granted the underwriter a 30-day option to purchase up to 1,875,000 shares of common stock to cover over-allotments, if any. Oppenheimer & Co. Inc. is acting as the sole bookrunner for the offering. ROTH Capital Partners and Ladenburg Thalmann Co. Inc. acted as financial advisers.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in